GGrantIndex
Sort

30,917 grants matching “tumor microenvironment”

MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA

$632,130
Jeffrey Noebels · Baylor College Of Medicine · R01 · FY2020 · CA

Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer

$632,111
Jim Rotolo · Sapience Therapeutics, Inc. · R44 · FY2024 · CA

Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism

$632,109
Nicholas C Denko · Ohio State University · R01 · FY2022 · CA

Core--Molecular Genetics

$631,979
John Jr D. Shaughnessy · Univ Of Arkansas For Med Scis · P01 · FY2007 · CA

Exploring PSMA Biology in Tumor neovasculature

$631,933
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

CANCAN - ROCHESTER

$631,930
Karen M Mustian · University Of Rochester · OT2 · FY2025 · CA

Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung

$631,889
Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA

Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance

$631,853
Emil Schueler · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Targeting dsRNA sensing and ADAR1 in melanoma

$631,778
Jeffrey J. Ishizuka · Yale University · R37 · FY2025 · CA

Targeting dsRNA sensing and ADAR1 in melanoma

$631,778
Jeffrey J. Ishizuka · Yale University · R37 · FY2024 · CA

Translational Pathology Core

$631,729
Peter A Jones · University Of Southern California · P30 · FY2014 · CA

DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy

$631,543
Karl T Kelsey · Brown University · R01 · FY2024 · CA

(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses

$631,495
Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2019 · CA

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy

$631,410
Melissa J Suter · Massachusetts General Hospital · R01 · FY2025 · CA

AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS

$631,336
Arvin Dar · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Extracellular pH mapping as therapeutic readout of drug delivery in glioblastoma

$631,151
Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2017 · EB

Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity

$631,104
Russell William Jenkins · Massachusetts General Hospital · R37 · FY2023 · CA

The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity

$631,075
Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA

IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors

$631,007
Andras A. Heczey · Baylor College Of Medicine · R01 · FY2025 · CA

Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence

$630,987
Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2024 · NS

Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome

$630,846
Huang Chiao Huang · Univ Of Maryland, College Park · R01 · FY2025 · CA

The role of the tumor biofilm in determining tissue tropism

$630,835
Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Cancer detection technology

$630,817
Wen-Tien Chen · Vitatex, Inc. · R42 · FY2007 · CA

Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer

$630,802
Timothy R Donahue · University Of California Los Angeles · R01 · FY2021 · CA

The CCK-B receptor signaling pathway as a driver of pancreatic cellular plasticity and carcinogenesis

$630,773
Jill P Smith · Georgetown University · R01 · FY2025 · CA